ABSTRACT
Background Breast cancer-related lymphedema (BCRL) requires a lifetime commitment to self-care.
Aims This is a study protocol for a pilot parallel-group randomized controlled trial which will assess the effectiveness of an online version of the General Exercise Management (GEM) program for patients with BCRL.
Methods Sixty patients will be recruited through online advertisements and randomly allocated to either an intervention or control group. The intervention group will be provided with an educational program on standard self-care for BCRL as well as the GEM program, while the control group will receive only the self-care education program. Both groups will participate in a six-month online program, perform daily self-checks and participate in monthly small-group sessions. All participants, session facilitators and a statistical analyst will be blinded to group allocation.
Anticipated Results The primary expected outcome is a reduction of BCRL symptoms, and the secondary outcomes are health-related quality of life and self- care adherence improvements.
Conclusions The findings will inform further investigation in a Phase III trial.
Declaration of Interest All authors declare that they have no competing financial interests.
This study was approved by the Institutional Review Board of Fukushima Medical University Hospital (REC2024-068) and registered with UMIN-CTR (UMIN000055357).
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
UMIN000055357
Funding Statement
This study was funded by JSPS KAKENHI Grant Number 23K09964
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board of Fukushima Medical University Hospital (REC2024-068) and registered with UMIN-CTR (UMIN000055357).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.